MedTrace Logo

Effect of an Infant Formula on Infant Growth, Health and Immune Functions

NCT00970398 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2013-04-22

No results posted yet for this study

Summary

The specific objectives of this study are to evaluate the effects of bovine milk osteopontin added to infant formula on infant growth, health and immune functions.

Conditions

  • Health
  • Growth
  • Immune Functions

Interventions

OTHER

Infant formula supplemented with bovine milk Osteopontin

Infant formula supplemented with bovine milk osteopontin at 50% and 100% levels of that of breast milk respectively.

OTHER

Standard infant formula

Infant formula without supplementation of bovine milk Osteopontin

Sponsors & Collaborators

  • Arla Foods

    collaborator INDUSTRY

  • Children's Hospital of Fudan University

    collaborator OTHER

  • University of California, Davis

    collaborator OTHER

  • University of Illinois at Urbana-Champaign

    collaborator OTHER

  • Biostime, Inc.

    lead INDUSTRY

Principal Investigators

  • Yongmei Peng, M.D. · Children's Hospital of Fudan University

  • Bo Lonnerdal, Ph.D. · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
30 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2012-09-30
Completion
2013-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00970398 on ClinicalTrials.gov